Acute heart drugs should be reconsidered for Maori and Pacific Islanders
Researchers at the University of Otago, New Zealand, say standard medication used for acute heart disease should be reconsidered for some Maori and Pacific Island patients because of drug resistance caused by high rates of Group A streptococcal infection, the same infection which leads to rheumatic fever.
The new study recently published in the prestigious British Medical Journal Clinical Pathology confirms research from Australia that indigenous people with acute coronary syndrome are more likely to have resistance to the standard heart drug streptokinase (SK).
Many people living in communities with high endemic levels of Group A strep, have been previously infected by Group A streptococcus bacteria and will have antibodies to streptokinase. Theres therefore a real risk that when they have a heart attack and are given this drug it will not work for them, explains Dr. Garry Nixon from the Department of General Practice and Rural Health in Dunedin.
The study involved 180 patients from the Hokianga, Thames and Central Otago admitted to hospital with a suspected heart attack.
Its clear from our results that patients in the Hokianga, the rural community with the highest proportion of Maori and lowest socio-economic status, have resistance to streptokinase medication which is 2.8 times higher than in Central Otago, with the lowest proportion of Maori and higher socio-economic status.
Dr. Nixon says these very significant differences mean that newer fibrinolytic heart drugs should be used for patients with heart attacks in predominantly Maori rural communities. However, he says these fibrinolytic agents which are not affected by the immune system, are more expensive than SK drugs, affecting their uptake.
This new research provides strong support for the recent moves away from SK as a standard treatment for heart attacks in rural New Zealand, particularly in predominantly Maori communities.
Perhaps most importantly this is a timely reminder of the need to exercise caution when translating the results of drug trials carried out on Caucasians to other ethnic groups such and Maori and Pacific Islanders. This is particularly important when a mechanism of drug resistance, such as the one outlined in this study, has been identified.
Dr. Nixon also points out that similar major health issues remain in the Pacific Islands where there are very high rates of Group A streptococcal infection, increasing rates of ischaemic heart disease and a continued reliance on streptokinase as a result of limited health budgets.
People living in Samoa, the Cook Islands, French Polynesia and Tonga have some of the highest rates of rheumatic fever in the world. The study also says that Pacific Islanders living in NZ have an incidence of rheumatic fever which is even higher than Maori (1.5-2 times).
Provided by University of Otago
-
High rates of acute rheumatic fever may be caused by household crowding
Nov 15, 2010 |
not rated yet |
0
-
Maori women have biggest increase in breast cancer rates
Feb 15, 2011 |
not rated yet |
0
-
Serious skin infection rates double in children since 1990
Apr 27, 2011 |
not rated yet |
0
-
Heart needs work after heart attack: Study challenges the notion that the heart must rest
Apr 14, 2011 |
not rated yet |
0
-
Tiny heart pump helps heart attack, heart failure patients
Mar 25, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013
-
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013
-
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
- More from Physics Forums - Medical Sciences
More news stories
Merck ends development of Parkinson's disease drug
(AP)—Merck & Co. says it is ending development of an experimental Parkinson's disease drug because the drug wasn't working.
Medications
May 23, 2013 |
1 / 5 (1) |
0
J&J expects 10-plus new drug applications by 2017
(AP)—Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during ...
Medications
May 23, 2013 |
5 / 5 (1) |
0
Experts favor US approval of Merck sleeping pill (Update)
An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.
Medications
May 22, 2013 |
not rated yet |
0
Glaxo, US partnering to develop new antibiotics
GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.
Medications
May 22, 2013 |
not rated yet |
0
Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine
The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published ...
Medications
May 22, 2013 |
not rated yet |
0
Engineered cytomegalovirus protects monkeys from HIV equivalent
(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...
Researchers identify first drug targets in childhood genetic tumor disorder
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
Hormone levels may provide key to understanding psychological disorders in women
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
Going live: Immune cell activation in multiple sclerosis
Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...
Help at hand for people with schizophrenia
How can healthy people who hear voices help schizophrenics? Finding the answer for this is at the centre of research conducted at the University of Bergen.
Alzheimer's disease, the soft target of the euthanasia debate
(Medical Xpress)—The way Alzheimer's disease is portrayed by advocacy groups and the media is having undue influence on the euthanasia debate, according to a Deakin University nursing ethics professor.
May 24, 2011
Rank: not rated yet
"Asians and Pacific Islanders have the highest mean levels
of iron in their blood of all ethnic groups involved, including African Americans, Caucasians, Hispanics, and Native Americans. Hemochromatosis, one of the most common inherited disorders among Caucasians, can lead to iron overload, or a buildup of iron in the body's organs. This extra iron, which can be easily treated if detected early, can increase the risk of diabetes, arthritis, sexual dysfunction, liver disease and liver cancer and heart disease."